These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 1907023)

  • 41. Unilateral lesion of the nigrostriatal pathway decreases the firing rate and alters the firing pattern of globus pallidus neurons in the rat.
    Pan HS; Walters JR
    Synapse; 1988; 2(6):650-6. PubMed ID: 3145582
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quantitative analysis of [3H]spiroperidol binding to rat forebrain sections: plasticity of neostriatal dopamine receptors after nigrostriatal injury.
    Neve KA; Altar CA; Wong CA; Marshall JF
    Brain Res; 1984 Jun; 302(1):9-18. PubMed ID: 6428705
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Spontaneous recovery from motor asymmetry in adult rats with 6-hydroxydopamine-induced partial lesions of the substantia nigra.
    Dravid A; Jaton AL; Enz A; Frei P
    Brain Res; 1984 Oct; 311(2):361-5. PubMed ID: 6149789
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Proceedings: Differences in circling responses following electrolytic and 6-hydroxydopamine lesions of the nigro-striatal pathway.
    Costall B; Marsden CD; Naylor RJ; Pycock CJ
    Br J Pharmacol; 1975 Oct; 55(2):289P-290P. PubMed ID: 1238135
    [No Abstract]   [Full Text] [Related]  

  • 45. Tactile extinction: distinguishing between sensorimotor and motor asymmetries in rats with unilateral nigrostriatal damage.
    Schallert T; Upchurch M; Lobaugh N; Farrar SB; Spirduso WW; Gilliam P; Vaughn D; Wilcox RE
    Pharmacol Biochem Behav; 1982 Mar; 16(3):455-62. PubMed ID: 7079281
    [No Abstract]   [Full Text] [Related]  

  • 46. Locomotor hyperactivity in neonatal rats following electrolytic lesions of mesocortical dopamine neurons.
    Heffner TG; Heller A; Miller FE; Kotake C; Seiden LS
    Brain Res; 1983 Jul; 285(1):29-37. PubMed ID: 6411289
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Striatal D1 dopamine receptor distribution following chemical lesion of the nigrostriatal pathway.
    Ariano MA
    Brain Res; 1988 Mar; 443(1-2):204-14. PubMed ID: 2965958
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibitory mechanisms in the substantia nigra and the dopamine pathway.
    Straughan DW; James TA
    Int J Neurol; 1979; 13(1-4):81-93. PubMed ID: 122391
    [No Abstract]   [Full Text] [Related]  

  • 49. Depletion of unilateral striatal dopamine impairs initiation of contralateral actions and not sensory attention.
    Carli M; Evenden JL; Robbins TW
    Nature; 1985 Feb 21-27; 313(6004):679-82. PubMed ID: 3974701
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Spontaneous regeneration of nigrostriatal dopaminergic neurons in MPTP-treated C57BL/6 mice.
    Mitsumoto Y; Watanabe A; Mori A; Koga N
    Biochem Biophys Res Commun; 1998 Jul; 248(3):660-3. PubMed ID: 9703982
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differential response of ventral midbrain and striatal progenitor cells to lesions of the nigrostriatal dopaminergic projection.
    Kay JN; Blum M
    Dev Neurosci; 2000; 22(1-2):56-67. PubMed ID: 10657698
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Localization of opiate receptors and enkephalins in the rat striatum in relationship with the nigrostriatal dopaminergic system: lesion studies.
    Pollard H; Llorens C; Schwartz JC; Gros C; Dray F
    Brain Res; 1978 Aug; 151(2):392-8. PubMed ID: 209865
    [No Abstract]   [Full Text] [Related]  

  • 53. Sequential administration of GDNF into the substantia nigra and striatum promotes dopamine neuron survival and axonal sprouting but not striatal reinnervation or functional recovery in the partial 6-OHDA lesion model.
    Rosenblad C; Kirik D; Björklund A
    Exp Neurol; 2000 Feb; 161(2):503-16. PubMed ID: 10686072
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evidence for a role of endogenous opioids in the nigrostriatal system: influence of naloxone and morphine on nigrostriatal dopaminergic supersensitivity.
    Hirschhorn ID; Hittner D; Gardner EL; Cubells J; Makman MH
    Brain Res; 1983 Jun; 270(1):109-17. PubMed ID: 6409355
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibitory influence of the nigrostriatal dopamine system on the striatal cholinergic neurons in the rat.
    Agid Y; Guyenet P; Glowinski J; Beaujouan JC; Javoy F
    Brain Res; 1975 Mar; 86(3):488-92. PubMed ID: 1116013
    [No Abstract]   [Full Text] [Related]  

  • 56. Adrenal medulla grafts enhance functional activity of the striatal dopamine system following substantia nigra lesions.
    Becker JB; Freed WJ
    Brain Res; 1988 Oct; 462(2):401-6. PubMed ID: 3142637
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT; White FJ
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dopamine-rich grafts ameliorate whole body motor asymmetry and sensory neglect but not independent limb use in rats with 6-hydroxydopamine lesions.
    Dunnett SB; Whishaw IQ; Rogers DC; Jones GH
    Brain Res; 1987 Jul; 415(1):63-78. PubMed ID: 3113665
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A two-population model of rat rotational behavior: effects of unilateral nigrostriatal 6-hydroxydopamine on striatal neurochemistry and amphetamine-induced rotation.
    Shapiro RM; Glick SD; Camarota NA
    Brain Res; 1987 Nov; 426(2):323-31. PubMed ID: 2446711
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Specificity of 6-hydroxydopamine-induced destruction of mesolimbic or nigrostriatal dopamine-containing terminals.
    Kelly PH; Joyce EM; Minneman KP; Phillipson OT
    Brain Res; 1977 Feb; 122(2):382-7. PubMed ID: 189878
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.